EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interactions of Potential Anticancer Drug 4-chloro-6-(1H-imidazo[4,5-b]phenazine-2-yl)benzene-1,3-diol with Supercoiled and Linear Plasmid DNAs

Dominika Janiszek, Anna Banasiak, Monika M. Karpinska, Andrzej Niewiadomy, Agnieszka Girstun, Hanna Elzanowska, Magdalena Maj-Zurawska, Pawel J. Kulesza

DNA · 03.06.2026 · 6 (2) · 29

DOI: 10.3390/dna6020029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DNA, online erschienen am 03.06.2026. Verfasst von Dominika Janiszek und 7 weiteren Autor:innen. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Does DNA superhelicity effect nucleic acid interactions with drugs? To test such a possibility, the interactions of the linear and superhelical forms of the pGEX-4T-2 plasmid have been investigated with a newly synthesized compound, 4-chloro-6-(1H-imidazo [4,5-b]phenazine-2-yl)benzene-1,3-diol, positively tested for the antiproliferative (cell growth-limiting) properties, important for the development of anticancer drugs.

Methods

The accumulation of the compound, and its possible reorientation (phase transition) within the plasmid layer adsorbed on a Glassy Carbon (GC) electrode has been monitored in 5 min. intervals using alternatively two voltammetric methods—Differential Pulse (DP), showing redox properties and—Alternating Current (AC), reflecting both redox and structural properties (capacity/resistance change related to DNA condensation) of the DNA-drug layers. Results and Discussion: The accumulation plots of the compound in plasmid layers are different for superhelical and linear pGEX-4T-2 and also depend on the DNA coverage by the compound. The reorientation (phase transition) occurs at a compound concentration 2 µM for the superhelical plasmid and 1.5 µM for the linear one, as compared to 8 µM for the compound layer formed on bare GC, thus proving the existence of the DNA–compound interactions. Interestingly, the phase transition is redox-sensitive, e.g., AC redox signal II is visible for the linear, but not for the superhelical plasmid, thus reflecting different orientation of the compound in these two types of pGEX-4T-2 plasmid, related to the condensation in the DNA–compound layer and seen as a decrease in the C/R signal.

Conclusions

The results suggest that the reorientation of the compound leading to plasmid condensation occurs differently in supercoiled and linear pGEX-4T-2 (redox specific accumulation and condensation).

Zitieren

APA

Janiszek, D., Banasiak, A., Karpinska, M. M., Niewiadomy, A., Girstun, A., Elzanowska, H., Maj-Zurawska, M., & Kulesza, P. J. (2026). Interactions of Potential Anticancer Drug 4-chloro-6-(1H-imidazo[4,5-b]phenazine-2-yl)benzene-1,3-diol with Supercoiled and Linear Plasmid DNAs. DNA, 6(2), 29. https://doi.org/10.3390/dna6020029

Vancouver

Janiszek D, Banasiak A, Karpinska MM, Niewiadomy A, Girstun A, Elzanowska H, et al. Interactions of Potential Anticancer Drug 4-chloro-6-(1H-imidazo[4,5-b]phenazine-2-yl)benzene-1,3-diol with Supercoiled and Linear Plasmid DNAs. DNA. 2026;6(2):29. doi:10.3390/dna6020029

BibTeX
@article{Janiszek2026,
  author = {Janiszek, Dominika and Banasiak, Anna and Karpinska, Monika M. and Niewiadomy, Andrzej and Girstun, Agnieszka and Elzanowska, Hanna and Maj-Zurawska, Magdalena and Kulesza, Pawel J.},
  title = {Interactions of Potential Anticancer Drug 4-chloro-6-(1H-imidazo[4,5-b]phenazine-2-yl)benzene-1,3-diol with Supercoiled and Linear Plasmid DNAs},
  journal = {DNA},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {29},
  doi = {10.3390/dna6020029}
}
Kostenlos starten →